Explore LENN nanoparticles, a groundbreaking technology for delivering mRNA therapies to bladder cancer cells with enhanced ...
News Medical on MSN
Purdue-developed LENN system enhances stability and targeting of mRNA cancer therapies
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
GlobalData on MSN
Moderna’s cancer vaccine plus Keytruda boosts RFS in melanoma study
A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.
Nature’s annual list of technologies to watch is a chance to celebrate progress and stimulate research into both ...
Amendment reduces and simplifies royalty structure on Teverelix ® from ~4% to 2% while preserving global rights and IP control The Company is ...
For decades, the global pharmaceutical industry has been impacted by a frustrating trend known as Eroom’s law.
The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research, and policy to ...
Ten stocks soared higher on Wednesday, mirroring a broader market rally, as investors took path from a combination of ...
US stocks spiked on Wednesday after President Trump announced the US and NATO "formed the framework of a future deal" on ...
Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...
An international team of scientists has designed a new type of therapy to target the mutant toxic RNA that causes myotonic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results